Biostax Corp (BTAX)

[goforthebet]

https://www.forbes.com/sites/andrebourque/2018/09/05/can-cats-and-dogs-help-reverse-the-stigma-of-marijuana/#17f7abd96bd1

Inspired conventional medicine manufacturers are well aware of these impressive numbers and are ramping up to take a chunk of the market. Pioneering biopharmaceutical company Immune Therapeutics (OTCQB:IMUN) recognized the massive potential in the growing animal health market and introduced a partnership to tap into it. “Pet owners and animal caregivers are embracing affordable, alternative medications in treating their animals,” CEO Noreen Griffin said in an interview.

After introducing two related patents, Griffin’s company swooped in to pick up part ownership of Cytocom, Inc., earning exclusive United States marketing and distribution rights for products containing Lodonal(TM) and Met-Enkelphline that have shown to treat inflammation, autoimmune disease disorders, and cancer in animals. “If we have medicine available to treat diseases, we have an obligation to provide it, not hold it back from society,” Griffin believes.